Mannkind (MNKD) Gross Margin (2016 - 2026)

Mannkind (MNKD) reported Gross Margin of 91.67% for Q1 2026, down 352.0% year-over-year from 36.38% in Q1 2025, and up 4.7% quarter-over-quarter from 87.56% in Q4 2025.

Mannkind (MNKD) Gross Margin (2016 - 2026) Analysis & Trends

Mannkind (MNKD) has 11 years of Gross Margin data on file, last reported at 91.67% in Q1 2026.

  • Gross Margin for Q1 2026 came in at 91.67%, down 352.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 91.53% (down 263.0% YoY), and the FY2025 annual result was 92.32%, down 158.0% from the prior year.
  • Gross Margin advanced to 91.67% in Q1 2026 per MNKD's latest filing, from 87.56% in the prior quarter.
  • Over five years, Gross Margin peaked at 172.48% in Q4 2022 and troughed at 1439.0% in Q2 2022.
  • A 5-year average of 1.71% and a median of 92.26% in 2024 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 152005 bps in 2022, then jumped 151020 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 172.48% in 2022, then retreated by 22 bps to 134.01% in 2023, then plunged by 30 bps to 93.74% in 2024, then retreated by 7 bps to 87.56% in 2025, then climbed by 5 bps to 91.67% in 2026.
  • Business Quant data shows MNKD's Gross Margin at 91.67% in Q1 2026, 87.56% in Q4 2025, and 94.52% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 91.67%

Historic Data

Download Data
DateValue
Mar 31, 2026 91.67%
Dec 31, 2025 87.56%
Sep 30, 2025 94.52%
Jun 30, 2025 93.98%
Mar 31, 2025 95.19%
Dec 31, 2024 93.74%
Sep 30, 2024 95.44%
Jun 30, 2024 92.26%
Mar 31, 2024 94.24%
Dec 31, 2023 134.01%
Sep 30, 2023 73.78%
Jun 30, 2023 71.20%
Mar 31, 2023 67.24%
Dec 31, 2022 172.48%
Sep 30, 2022 58.75%
Jun 30, 2022 -1,439.00%
Mar 31, 2022 -6.14%
Dec 31, 2021 -163.60%
Sep 30, 2021 82.84%
Jun 30, 2021 81.05%